About: A study on the relationship between BCG vaccination and Covid-19 prevalence: Do other confounders warrant investigation?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A study on the relationship between BCG vaccination and Covid-19 prevalence: Do other confounders warrant investigation? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	A study on the relationship between BCG vaccination and Covid-19 prevalence: Do other confounders warrant investigation?
Creator	Mariita, Richard Musila, Jonathan
source	MedRxiv
abstract	The Covid-19 pandemic, which originated from Wuhan, Hubei province, China, and quickly spread to the rest of the globe is caused by SARS-CoV-2, a single-stranded RNA virus. Preliminary data suggest a relationship between the BCG vaccine and the prevalence of Covid-19. The BCG vaccine is used in the prevention of tuberculosis, a disease that is most prevalent in developing countries. To determine the potential protective role of BCG vaccination, this study investigated the occurrence of Covid-19 and the relationship between the spread of Covid-19 in countries that offer BCG vaccination and those that do not. The study also performed a phylogenetic analysis of the strains involved in the Covid-19 outbreak from the representative countries. To achieve the objectives, the study utilized publicly available data on population size, vaccination coverage, and Covid-19 cases. Phylogenetic analysis was used to determine if some SARS-CoV-2 strains were more prevalent than others. The study revealed a significant negative trend between countries that offer the BCG vaccine to the general population and the reported cases of Covid-19. The study proposes future molecular and immunological analyses to determine the potential role of BCG vaccination in protection against Covid-19. This will determine if BCG has antiviral properties, with the possibility of recommending it for widespread use if supported by scientific data.
has issue date	2020-05-11(xsd:dateTime)
bibo:doi	10.1101/2020.05.06.20093138
has license	medrxiv
sha1sum (hex)	ee70819f55471e93c22ce4f697c08e7dccb9ad7a
schema:url	https://doi.org/10.1101/2020.05.06.20093138
resource representing a document's title	A study on the relationship between BCG vaccination and Covid-19 prevalence: Do other confounders warrant investigation?
resource representing a document's body	covid:ee70819f55471e93c22ce4f697c08e7dccb9ad7a#body_text
is schema:about of	named entity 'supported' named entity 'Covid-19' named entity 'study' named entity 'BCG vaccination' named entity 'BCG' »more»

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software